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Key points summary 
 Cystic fibrosis transmembrane conductance regulator (CFTR) is an important ion 
channel in epithelial cells. Its malfunction has several serious consequences, like 
developing or aggravating acute pancreatitis (AP).  
 Here, we investigated the localization and expression of CFTR during cerulein-
induced AP in mice and determined the effects of CFTR corrector (VX-661) and 
potentiator (VX-770) on disease severity. 
 CFTR mRNA expression was significantly increased, and mislocalization of CFTR 
protein was observed in AP compared to the control group.  
 Interestingly, pre-treatment of AP mice with VX-661 + VX-770 significantly 
reduced the extent of pancreatic tissue damage by 20-30%.  
 In vitro administration of VX-661 + VX-770 significantly increased the fluid 
secretion of ducts derived from AP animals. 
 Based on our results, the utilization of CFTR correctors and potentiators should be 
further investigated in AP. 
  
 




Cystic fibrosis transmembrane conductance regulator (CFTR) has essential role in 
maintaining pancreatic ductal function. Impaired CFTR function can trigger acute 
pancreatitis (AP) and exacerbate disease severity. We aimed to investigate the localization 
and expression of CFTR during AP, and determined the effects of CFTR corrector (VX-661) 
and potentiator (VX-770) on disease severity. 
AP was induced in FVB/n mice by 6-10 hourly intraperitoneal injections of 50µg/kg cerulein. 
Some mice were pre-treated with 5-6 daily injections of 2mg/kg VX-661+VX-770. Control 
animals were administered physiological saline instead of cerulein and DMSO instead of VX 
compounds. AP severity was determined by measuring laboratory and histological 
parameters; CFTR and CK19 expressions were measured. Activity of ion transporters was 
followed by intracellular pH or fluid secretion measurement of isolated pancreatic intra-
/interlobular ducts. 
Cerulein-induced AP severity was greatest between 12-24h. CFTR mRNA expression was 
significantly increased 24h after AP induction. Immunohistochemistry demonstrated 
disturbed staining morphology of CFTR and CK19 proteins in AP. Mislocalization of CFTR 
protein was observed from 6h, while expression increased at 24h compared to control. Ductal 
HCO3
−
 transport activity was significantly increased 6h after AP induction. AP mice pre-
treatment with VX-661+VX-770 significantly reduced the extent of tissue damage by about 
20-30%, but other parameters were unchanged. Interestingly, VX-661+VX-770 in vitro 
administration significantly increased the fluid secretion of ducts derived from AP animals. 
This study described the course of the CFTR expression and mislocalization in cerulein-
induced AP. Our results suggest that the beneficial effects of CFTR correctors and 
potentiators should be further investigated in AP. 
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Introduction 
The exocrine pancreas mainly consists of acinar and ductal cells (Czakó et al., 2009). 
Ductal cells provide structural framework for pancreas, convey digestive enzymes secreted 
by acini, neutralize the acidic fluid of the acini as well as the gastric juice entering into the 
duodenum (Pallagi et al., 2015). Ductal cells produce 2.5 litre of alkaline secretion daily 
which may contain up to 140 mM HCO3
−
 (Hegyi & Rakonczay, 2015). Several transporters 
and different mechanisms are involved in fluid and HCO3
−









 exchanger (NHE) or H
+
-ATPase contribute to 
HCO3
-
 uptake into ductal cells. In addition, CO2 diffuses into the cells from the blood and 
carbonic anhydrases convert it to HCO3
−
. Apical ion transporters which participate in HCO3
−
 
secretion are solute carrier family 26 A3 and A6 (SLC26A3, SLC26A6), cystic fibrosis 
transmembrane conductance regulator (CFTR), and Anoctamin-1 (ANO1). Among these ion 
transporters, CFTR is the most prominent due to its numerous roles in secretion and 
regulation (Hegyi et al., 2016; Kim et al., 2020). In fact, CFTR is present in these epithelial 




 secretion, and 
regulation of ion channels like SLC26A6 (Rakonczay et al., 2008). CFTR is mainly 
stimulated by cyclic AMP; however, intracellular Ca
2+
 concentration also influences its 
activity. CFTR alters Ca
2+
 signalling through direct connection with sarco/endoplasmic 
reticulum Ca
2+
-ATPase (SERCA) and plasma membrane Ca
2+
-ATPase (PMCA) channels 
(Philippe et al., 2015) or by functional coupling with transient receptor potential canonical 6 
(Antigny et al., 2008). Moreover, the presence of CFTR is necessary for proper function of 
mitochondria (Madácsy et al., 2018).  
Acute pancreatitis (AP) is the sudden inflammation of the pancreas and one of the most 
common gastrointestinal diseases (Peery et al., 2015). Its incidence shows increasing 
tendency, and it is more than 30 per 100 000 population in Europe (Roberts et al., 2013 and 
2017). The two main causes of AP are excessive alcohol consumption and gallstone diseases 
(Forsmark et al., 2016; Párniczky et al., 2016). The pathomechanism of AP is complex and 
not fully revealed. The underlying mechanisms of AP involve toxic intracellular Ca
2+
 
overload inducing premature activation of digestive enzymes, NF-κB activation, impaired 
autophagy, mitochondrial dysfunctions, and impairment of ductal function (Barreto et al., 
2021). The therapy of AP is only supportive and there is no specific drug against it (Crockett 
et al., 2018). 
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Pancreatic ductal cell damage also occurs during AP due to disease-inducing factors 
(such as ethanol and bile acids) and intraductal enzyme activation. Furthermore, these factors 
dose-dependently affect ductal function as well (Hegyi and Rakonczay, 2015). Low 
concentrations of ethanol and bile acids stimulate, while higher concentrations inhibit ductal 
functions (Judák et al., 2014; Maléth et al., 2011 and 2015; Venglovecz et al., 2008). 
Activated trypsin in ductal lumen inhibits CFTR via proteinase-activated receptor 2 (Pallagi 
et al., 2011). Moreover, the impaired ductal function due to CFTR mutations in cystic fibrosis 
(Ooi et al., 2011) or ductal obstructions (Li and Tian, 2017; Mujica et al., 2000) can lead to 
chronic pancreatitis or AP, respectively. CFTR inhibition in AP and the consequent disease 
aggravation by ductal impairment cause a vicious cycle.  
Recently, several drugs were clinically approved to improve CFTR expression, 
localization and function by correcting protein folding or to potentiate its activity in cystic 
fibrosis (Amaral, 2021). Among them the CFTR corrector lumacaftor (VX-809), tezacaftor 
(VX-661), elexacaftor (VX-445) and the CFTR potentiator, ivacaftor (VX-770) were the 
most effective. CFTR activity markedly contributes to proper ductal function. The 
disturbance or reduction of ductal function is one of the key factors in initiation of AP.  
In the past two decades, the earlier mentioned studies mainly utilized healthy ducts to 
reveal how different etiological factors of AP (ethanol, bile acids, unsaturated fatty acids, 
etc.) affect pancreatic ductal epithelial functions. Therefore, the complex effects of AP were 
not investigated on ducts. Our first aim was to reveal changes in pancreatic ductal function 
and CFTR expression during the course of AP. Then our second aim was to test whether the 
correction and potentiation of CFTR affect the disease severity. 
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Materials and methods 
Animals 
8-10 week-old male FVB/n mice were used for experiments. The animals were obtained from 
Charles River Laboratories Inc. (Wilmington, MA, USA) and housed in the departmental animal 
facility in a constant room temperature of 24 °C with a 12 h light-dark cycle and were allowed ad 
libitum to water and standard laboratory chow (Biofarm, Zagyvaszántó, Hungary). Animal 
experiments were performed in compliance with the European Union Directive 2010/63/EU and the 
Hungarian Government Decree 40/2013 (II.14.). Experiments were approved by both local 
(University of Szeged) and national ethics committees (X./3355/2017) for investigations involving 
animals. In our study, all animals were sacrificed via intraperitoneal (i.p.) injection of 200 mg/kg 
pentobarbital (Bimeda MTC, Cambridge, Canada). 
 
Materials 
All chemicals were obtained from Merck/Sigma-Aldrich Kft. (Budapest, Hungary) unless 
indicated otherwise. Cerulein (Cer) was acquired from Glentham Life Sciences (Corsham, United 
Kingdom); VX-661 (tezacaftor) and VX-770 (ivacaftor) were obtained from Cayman Chemical (Ann 
Arbor, MI, USA); amylase activity kit was procured from Diagnosticum (Budapest, Hungary); anti-
CFTR antibody was purchased from Alomone Labs (Jerusalem, Israel); AlexaFluor488 goat anti‐
rabbit secondary antibody and Hoechst 33342 were from ThermoFisher Scientific (Waltham, MA, 
USA); anti-Cytokeratin-19 antibody was obtained from Abcam (Cambridge; United Kingdom); 
RNA/cDNA kits: DreamTaq DNA Polymerase, DreamTaq™ Green Buffer, dNTP mix 25 mM, 
GeneRuler 100 bp DNA Ladder, TRIzol™ Plus RNA Purification Kit, UltraPure™ Ethidium 
Bromide, GeneRuler™ 1 kb Plus DNA Ladder, High-Capacity cDNA Reverse Transcription Kit and 
Luminaris Color HiGreen qPCR Master Mix were obtained from ThermoFisher Scientific; 2.7‐bis‐(2‐
carboxyethyl)‐5‐(and‐6‐) carboxyfluorescein‐acetoxymethylester (BCECF‐AM) was purchased from 
Biotium (Fremont, CA, USA). 
Cer, VX-661 and VX-770 were dissolved in DMSO and Cer was further diluted in physiological 
saline (PS) before injection. The solutions used for ductal (intracellular pH, pHi, and fluid secretion) 
measurements and immunohistochemistry are presented in Table 1.  
 




















NaCl 140 115 95 150 
KCl 5 5 5 - 
MgCl2 1 1 1 - 
CaCl2 1 1 1 - 
HEPES 10 - - - 
Glucose 10 10 10 - 
NaHCO3  25 25 - 
NH4Cl   20 - 
Trizma 
base 
   50 
pH 7.4 set by 5 % CO2 and 
95 % O2 bubbling 
set by 5 % CO2 and 
95 % O2 bubbling 
7.4 
 
In vivo experiments: acute pancreatitis induction and treatment with VX-661 + VX-770  
Two different experimental setups were utilized in this work (Fig. 1). In the first part of the 
study, AP was evoked to reveal its effect on CFTR expression and ductal function (Fig. 1A). In the 
second part of our work, CFTR corrector and potentiator (VX-661 and VX-770, respectively), 
administration was combined with AP induction (Fig. 1B). Necrotizing AP was induced by hourly i.p. 
injection of 6 or 10 × 50 µg/kg Cer (5 µg/ml) in FVB/n mice as described previously (Pallagi et al., 
2014). VX-661 and VX-770 were administered i.p. at 2 mg/kg once a day before and during AP. The 
doses of VX-661 and VX-770 were chosen based on the study by Zeng et al. (2017). Control groups 
were given PS solution instead of CER, and DMSO instead of VX compounds. Animals were 
sacrificed at 0, 6, 12, 24, 48, and 72 h when the effect of AP on ducts and CFTR were investigated. In 
case of VX-661 + VX-770 combination, the first termination time was at 24 h and the second at 48 h.  
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Immediately after opening the abdomen, a small piece of pancreas was removed for measurement 
of mRNA expression. Then blood was collected through cardiac puncture (⁓400µl) and placed on ice 
until serum separation. After that, the remaining part of the pancreas was rapidly excised and was 
cleaned from fat and lymph nodes on ice, then cut into pieces. A small piece of the pancreatic tissue 
was fixed in 8% neutral formaldehyde solution for histological analysis, the rest was immediately 
frozen in liquid nitrogen and stored at −80 °C until biochemical assay. For dry-wet mass 
measurements, a small sample was stored in an Eppendorf tube. For immunohistochemical staining 
procedures, a small piece of the pancreas was frozen in cryomatrix at –80 °C. Blood samples were 




Pancreatic myeloperoxidase (MPO) activity is a hallmark of leukocytic infiltration and was 
measured according to Kuebler et al. (1996). MPO activities were normalized to total protein content 
as measured by the Lowry method (Lowry et al., 1959). To evaluate pancreatic water content, the wet 
weight (WW) of the pancreata was measured, then the tissues were dried for 48 h at 100 °C and the 
dry weight (DW) was also measured. The tissue water content was calculated as: [(WW-
DW)/WW]×100. Serum amylase activity was measured on a Fluorostar Optima plate reader from 
BMG Labtech (Ortenberg, Germany) with a colorimetric kinetic method using a commercial amylase 
activity kit. Absorbance of the samples was detected at 405 nm. 
 
Histological examination 
Formalin-fixed and paraffin embedded pancreatic tissues were sectioned to 3 µm. These sections 
were stained with hematoxylin and eosin and were scored by independent experts blinded to the 
experimental protocol, then the scores related to the same samples were averaged. To quantify cellular 
damage, leukocyte infiltration and oedema grades a semiquantitative scoring system was used 
according to Kui et. al (2015). Briefly, edema was scored from 0‑3 points (0: none; 1: patchy 
interlobular; 2: diffuse interlobular; 3: diffuse interlobular and intra-acinar), leukocyte infiltration 
from 0‑4 points (0: none; 1: patchy interlobular; 2: moderate diffuse interlobular; 3: mild diffuse 
interlobular; 4: diffuse interlobular and intra-acinar). Percentage of cellular damage was also 
evaluated. In addition, the extent of vacuolization was determined (0: none; 1: diffuse/mild; 2: 
diffuse/moderate; 3: diffuse/severe). 
 
mRNA extraction and reverse transcription 
A small piece of pancreas was placed on ice in 1 ml TRIzol reagent in a 13 ml centrifuge tube 
and was homogenised immediately with IKA Ultra Turrax (Type: TP18/10). Then the tissue 
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homogenate was instantly placed on liquid nitrogen and stored at –80 °C until use (for max. of 1 or 2 
days). Total RNA purification was performed in three steps. In the first step, phase separation was 
performed by adding 200 µl of chloroform to the samples and shaking vigorously for 15 min, 
allowing to stand, and then centrifuging at 12000 g for 15 min at 4 °C. From the resulting 3 phases, 
the top aqueous phase was aspirated into an empty Eppendorf tube and 500 µl of isopropanol was 
added. This was vortexed and then allowed to stand for a few min and after that it was centrifuged at 
12000 g for 10 min at 4 °C. RNA precipitated in the Eppendorf tubes. The supernatant was removed 
and 1 mL of 75% alcohol was added. It was vortexed and centrifuged at 7500 g for 5 min at 4 °C. 
After removal of the supernatant, the excess ethanol was evaporated briefly and then the RNA was 
redissolved in 70 µl of RNAse-free water. RNA was stored at –80 °C until further use.  
RNA concentration was measured using a NanoDrop instrument from ThermoFisher Scientific 
(Waltham, MA, USA). We considered the optimal ranges for RNA: A260/A280: 1.9-2.1 and A260-
A230: 1.8-2.5. RNA integrity was examined after agarose gel electrophoresis. 
2 µg of total RNA was used for reverse transcription. PCR protocol for the reverse transcription was 
started at 25 °C for 10 min, followed by 37 °C for 2 h, 85 °C for 5 min, then 4 °C. cDNA was stored 
at –20 °C until further use. 
 
Quantitative real-time PCR 
The total reaction mix volume was 10 µl. The components of the reaction mixture were the 
following: 1.67 µl cDNA sample, 0.4 mM forward and reverse primer, Luminaris Color HiGreen 
qPCR Master Mix and nuclease-free water. The protocol for the quantitative real-time PCR was 
started at 50 °C for 2 min, then 95 °C for 10 min, followed by 40 cycles of amplification: 95 °C for 15 
sec, 60 °C or 64 °C for 30 sec (depending on the primers), 72 °C for 30 sec then a Melt Curve from 70 
°C to 95 °C for 5 sec with 0.5 °C increment. Our primers used in relative gene expression 
measurements (Table 2.) were checked with the Oligoanalyzer program from Integrated DNA 
Technologies (Iowa, USA; https://www.idtdna.com/pages/tools/oligoanalyzer). Gradient PCR was 
and performed to determine the appropriate annealing temperature of the primers. The Slc26a3 and 
Slc26a6 primer pairs have been used previously in our laboratory (Molnár et al., 2020). The 
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The cryomatrix-embedded pancreatic tissues derived from animals were sliced by a Leica Cryostat at 
7 µm thickness. Sections were fixed in 2 % paraformaldehyde for 20 min. Washing periods were 
administered with Tris‐buffered saline (TBS) solution (pH 7.4). Antigen retrieval was performed with 
0.1 % Triton X-100 in TBS solution for 10 min. Blocking was performed for 1 h with 5 % bovine 
serum albumin‐TBS solution. These sections were then incubated with anti-CFTR rabbit polyclonal 
antibody (dilution 1:400) overnight at 4 °C. The following day the samples were incubated with 
AlexaFluor 488 goat anti‐rabbit secondary antibody (dilution 1:500) for 1 h in the dark at room 
temperature. After a few washing steps, co-immunostaining was performed with the AlexaFluor647-
conjugated CK19 antibody (dilution 1:100, CK19 is a ductal marker protein). Nuclei were 
counterstained with Hoechst 33342 (dilution 1:400). Tissue slices were mounted with Fluoromount 
and then analysed using a Zeiss LSM 880 confocal laser scanning microscope (Carl Zeiss Technika 
Kft., Budapest, Hungary). To quantify pancreatic ductal CFTR and CK19 expression, three or four 
representative large tile scan images were taken from each group by with the Zeiss LSM 880 
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microscope (in average 1500 x 1000 µm). Image J software was used to convert images to grey scale 
(16 bit), and threshold function was used to select the positively stained area based on the 
fluorescence intensities. The area without tissue were excluded from the calculation. 
 
Fluid secretion and intracellular pH measurement in cultured pancreatic ducts 
Intra-/interlobular pancreatic ducts were isolated from control and AP mice after collagenase 
digestion by microdissection as described previously (Argent et al., 1986). In case of fluid secretion 
measurements, ducts were cultured for 6-14 h (which allowed sealing of their open ends) at 37 °C in a 
humidified atmosphere containing 5% CO2. Some ducts were treated with 3 µM VX-661 and 1 µM 
VX-770 during incubation, while others subjected to the vehicle (0.5% DMSO) or only the medium. 
Fluid secretion into the closed luminal space of the cultured pancreatic ducts was analysed using 
a swelling method (Fernandez-Salazar et al., 2004; Pallagi et al., 2014). Thenducts were transferred to 
a perfusion chamber and were attached to a coverslip pre-coated with 0.05 mg/ml poly-L-lysine. The 
ducts were perfused with different solutions in the following order: 1) standard HEPES, 2) standard 
HEPES with 5 µM forskolin 3) standard HCO3
−
/CO2 with 5 µM forskolin. Bright-field images were 
acquired at 1-min intervals using a Zeiss Axio Observer 7 with CMOS camera (Orca Flash4.0LT, 
Hamamatsu Photonics, Hamamatsu City, Japan). The integrity of the duct wall was checked at the end 
of each experiment by perfusing the chamber with a hypotonic solution (standard HEPES-buffered 
solution diluted 1:1 with distilled water). Digital images of the ducts were analysed using ImageJ 
software (National Institutes of Health, Bethesda, MD, USA) to obtain values for the area 
corresponding to the luminal space in each image. 
pHi measurements were started immediately after isolation and were carried out within 8 h 
thereafter using IX71 live cell imaging fluorescence microscope and Cell
R
 imaging system from 
Olympus (Budapest, Hungary). Alkali load method was applied to measure pancreatic ductal HCO3
−
 
secretion (Venglovecz et al., 2008). The HCO3
−
 secretion was estimated by the rate of pHi recovery 
from alkalization. The isolated ducts were loaded with pH sensitive BCECF-AM fluorescent dye (2 
µM) for 20-30 min in standard HEPES solution at 37 °C in a humidified atmosphere containing 5 % 
CO2. After that, ducts were perfused with solutions in the following order: 1) standard HEPES, 2) 
standard HCO3
−
/CO2, 3) NH4Cl in HCO3
−
/CO2, 4) standard HCO3
−
/CO2, 5) standard HEPES. 
Exposing ducts to 20 mM NH4Cl caused alkalization of pHi. The perfusion rate was 4-6 ml/min. Four 
to ten small areas (region of interests, ROIs) of 5-10 cells in each intact duct were monitored. The 
ducts were excited with light at wavelengths of 490 and 440 nm, and the 490/440 fluorescence 
emission ratio was measured at 535 nm. One pHi measurement was obtained per second. The extent 
of pHi change (ΔpH/Δt) was calculated by linear regression analysis.  
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Statistical analysis 
Graphs were generated by GraphPad Prism 9.2.0 (GraphPad Software, San Diego, CA, USA). 
Data are presented as means ± SDExperiments were evaluated by one- or two-way ANOVA followed 




The course of cerulein-induced acute pancreatitis severity 
The progression of Cer-induced AP was followed from 0 to 72 h. Representative 
histological images show pancreatic tissues of mice sacrificed at different time points (Fig. 
2A). Cer injection caused the greatest degree of cell damage at 24 h (Fig. 2A-B). This is 
adequately supported by the scoring results of vacuolization (Fig. 2C). Cell damage and 
vacuolization were significantly decreased at 48 and 72 h compared to 24 h groups (cell 
damage: P = 0.0493, P < 0.0001 respectively; vacuolization: P = 0.0152, P = 0.0004 
respectively). Leukocyte infiltration was increased at 6, 12, 24, and 72 h after the first Cer 
injection compared to control (Fig. 2D; P = 0.0002, P < 0.0001, P < 0.0001, P = 0.0582, P = 
0.0165 respectively). Changes in pancreatic MPO activity closely followed leukocyte 
infiltration and showed marked increases at 12 and 24 h (Fig. 2E). AP evoked significant 
elevations in pancreatic water content and serum amylase activity at 12 and 24 h compared to 
the control (0h) group (Fig. 2F-G; water content: P = 0.0069, P = 0.0038; serum amylase 
activity: P < 0.0001, P = 0.0009). Serum amylase activity was highest at 12 h, which then 
decreased back to control levels after 48 h (Fig. 2G). At 48-72 h, almost all histological and 
laboratory parameters showed decreased tendency compared to the 12 or 24 h groups. 
 
Changes in CFTR expression and staining morphology during acute pancreatitis 
Fig. 3 shows the mRNA expressions and protein staining during the time course of AP. 
The relative gene expression of Cftr mRNA was markedly increased during AP from 24 h 
compared to the control (Fig. 3A, P = 0.0016). The peak was detected at 48 h and almost 20-
fold increase was measured in Cftr mRNA amount compared to the heathy group (P < 
0.0001). This tendency was also observed in case of the ductal marker Ck19 (Fig. 3B), but its 
mRNA had less marked increased expression than Cftr. Ck19 mRNA expression was highest 
at 12 and 24 h after the initiation of AP. Slc26a3 mRNA expression was also increased at 24 
h, while the mRNA of Slc26a6 was decreased between 24 and 72 h (Fig. 3C-D).  
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The percentage of area staining of CFTR and CK19 proteins was determined by fluorescent 
immunostainings. Fig. 3E shows representative images which was used to calculation of area 
staining. Six percent of pancreatic tissue in untreated group stained for CFTR (Fig. 3F). At 
the beginning of AP (6 and 12 h), the CFTR staining area showed decrease in tendency, but 
at 24 h the protein expression significantly increased compared to the control (P = 0.0402) or 
6-12 h (P = 0.0118, P = 0.0001, respectively) treatment groups. The increase of CFTR protein 
expression is in accordance with the results of the mRNA measurements. CK19 staining area 
in the control group was approximately 20 % (Fig. 3G). This area of CK19 decreased in 
pancreatic tissue at the beginning of AP (6 h), while later on CK19 expression did not differ 
from the control group. 
Detailed ductal structures were also captured after CFTR and CK19 immunostaining 
(Fig. 4). The physiological location of CFTR is in the apical membrane of the pancreatic 
ducts. Clearly, detectable ductal morphology was observed in the control animals in cases of 
both CFTR and CK19. The lumens of the stained intralobular ducts were approximately 2-3 
μm in diameter, which could be followed through several μm. The nuclei were located close 
to the ductal lumen. Bigger interlobular ducts did not stainfor CFTR. Notably, AP even from 
6 h disturbed the characteristic structure of the ductal tree. CFTR was mislocalized and both 
CFTR and CK19 proteins showed diffuse and perinuclear appearance. At 72 h after the 
initiation of the disease, some duct like structures appeared in stained tissue slices (Fig. 4, 
yellow arrow). CK19 and CFTR showed similar staining morphologies at all time points. 
Pancreatic ductal HCO3
− secretion during the course of acute pancreatitis 
Alkali load method and measurement of pHi changes during the cellular regeneration 
phase provided estimation of the HCO3
−
 secretory function of isolated pancreatic ducts. This 
is mainly carried out by apical transporters (CFTR, SLC26A3, SLC26A6). When cellular 
alkalosis was stopped by ammonium elimination, the cells shortly became acidotic. The 
cellular regeneration from acidosis can activate basolateral transporters (eg. NBC, NHE or 
H
+
-ATPase). Therefore, the regeneration rate from acidosis refers to the activity of 
basolateral transporters. At the early phase (6 h) of AP, HCO3
−
 secretion by apical 
transporters was significantly increased as demonstrated by regeneration from alkali load 
(Fig. 5A; 0h vs. 6h: P = 0.0071). Basolateral transporter activity was also elevated when 
regeneration from acidosis was measured (Fig. 5B; 0h vs. 6h: P = 0.0402). However, from 12 
to 72 h, the response to alkalosis and acidosis were not significantly different vs. the control 
group. 
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The combination of CFTR corrector VX-661 and CFTR potentiator VX-770 decreased the severity of AP 
The combination of VX-661 and VX-770 by itself did not induce any gross adverse 
effects. In fact, the morphology of the pancreas was normal after administration of VX-
661+VX-770, and the histological and laboratory parameters were also similar to the non-
treated group (data not shown). The effects of VX-661+VX-770 on AP are shown in Fig. 6. 
Representative histological sections showed that AP damaged the pancreatic tissue and VX-
661+VX-770 combination could ameliorate this damage (Fig. 6A). Almost all measured 
parameters were increased in AP groups compared to the control group (Fig. 6B-F). VX-
661+VX-770 pre-treatment significantly decreased AP severity based on the extent of cell 
damage (Fig. 6B, P = 0.0093). We could not observe any significant difference in 
vacuolization over time or treatment in the AP groups (Fig. 6C). Measurements of pancreatic 
leukocyte infiltration and MPO activity showed similar kinetics, with no significant 
difference in the AP groups (Fig. 6D-E). No change was observed in pancreatic water content 
when the AP group was compared with the AP+VX-661+VX-770 group (Fig. 6F). In case of 
serum amylase activity, no significant difference was measured between the control and 
treated groups (Fig 6G). 
The effect of CFTR corrector VX-661 and CFTR potentiator VX-770 on ductal morphology and protein 
expression in acute pancreatitis 
CFTR and CK19 co-immunostainings showed normal ductal structures at 24 and 48 h in 
control groups (Fig. 7). AP disturbed the staining morphology of CFTR and CK19 at both 24 
and 48 h. VX-661+VX-770 pre-treatment could not restore or improve the damaged ductal 
structure as demonstrated by CFTR or CK19 staining (Fig. 8). CFTR protein expression was 
increased by AP (P = 0.0022) while CK19 expression (P= 0.7637) was unchanged (Fig. 8B-
C). VX-661+VX-770 pre-treatment had no effect on AP-induced alterations of CFTR and CK 
protein expressions.  
 
VX-661 and VX-770 enhance fluid secretion in isolated pancreatic ducts from mice with acute 
pancreatitis 
To investigate if fluid secretion is influenced by the treatment with VX-661 and VX-770, 
isolated ducts (treated with or without 0.5 % DMSO/VX-661 and VX-770) from control and 
AP mice were used, and their swelling was followed (Fig. 9). The cAMP agonist forskolin 
treatment significantly enhanced the swelling of ducts from control animals, especially in 
HCO3
-
/CO2 containing buffer. DMSO administration did not influence changes in relative 
ductal luminal volume. Therefore, the corresponding groups treated with or without DMSO 
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were combined (i.e. cerulein and cerulein + DMSO). Ducts isolated from cerulein-treated 
animals showed tendency towards increased swelling rates compared to the PS-treated 
control mice, but this did not reach statistical significance (Fig. 9). Interestingly, VX-661 and 
VX-770 treated ducts showed significantly increased fluid secretory rate compared to the 
non-VX treated ducts derived from AP animals (Fig. 9B, P = 0.0146).  
 
Discussion 
The pathomechanism of AP is complex and the underlying processes are not completely 
understood. However, the important role of ductal impairment and the CFTR ion channel 
function in the pathomechanism of the disease is already known (Barreto et al., 2021; Hegyi 
et al., 2015). Recently several drugs appeared commercially (eg. VX-661 or VX-770) or are 
in clinical phases to restore impaired CFTR ion channel activity or the protein expression in 
diseases caused by mutations (e.g. cystic fibrosis). In this study, we found mislocalization of 
ductal CFTR during AP in mice, so the combination of VX-661 and VX-770 was applied to 
improve the function of pancreatic ducts during AP. Furthermore, to our best knowledge, this 
is the first study which investigated the ex vivo ductal function on pancreatic ducts isolated 
during AP as well.  
Pallagi et al. (2011) have shown that premature activation of trypsin in AP causes ductal 
CFTR inhibition through proteinase-activated receptor 2 and elevation of intracellular Ca
2+
 
concentration. Our study demonstrates that not just functional inhibition, but also 
mislocalization of CFTR may cause the decrease of ductal function. Our results demonstrate 
that AP induces the loss of CFTR staining along the ductal lumen, and CFTR staining was 
observed in the perinuclear region. Presumably, the inflammation and cellular stress direct 
CFTR proteins into proteosomes for degradation (Ahner et al., 2013). Interestingly, the 
mRNA expression of Cftr was unchanged in the beginning of AP (6-12 h) and was increased 
from 24 h. The protein expression of CFTR followed the mRNA changes and increased after 
24h. Similar measurements were performed in our earlier work (Maléth et al., 2015). Human 
pancreata derived from patients with alcoholic AP and chronic pancreatitis were compared to 
normal pancreas. Alcoholic AP decreased CFTR mRNA and protein expressions in human 
samples, while chronic pancreatitis caused marked increase in mRNA expression and in 
cytoplasmic localization of CFTR proteins. In a cell culture and guinea pig AP model, Maléth 
et al. (2015) also demonstrated that ethanol and its metabolites decrease Cftr mRNA and 
protein expressions. Furthermore, ethanol and palmitoleic acid induced AP also caused CFTR 
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mislocalization in guinea pig. Consequently, the results of the present study and our earlier 
investigation (Maléth et al., 2015) showed that two different animal models of AP cause 
CFTR mislocalization, suggesting that this adverse effect is independent of the disease 
aetiology.  
The ex vivo HCO3
-
 secretion of isolated ducts was increased at 6 h after AP initiation, 
whereas at later time points it was similar to that of the non-AP group. These isolated ducts 
were derived from interlobular space and had bigger lumens, approximately 20-130 µm. 
However, CFTR expression was not observed in these ducts, only smaller (2-3 µm luminal 
diameter) intercalated ducts were stained for CFTR, as it was also shown by Burghardt et al. 
(2003) and Marino et al. (1991) in human samples. However, Fernandez-Salazar et al. (2004), 
Pallagi et al. (2014) and this work demonstrated functional CFTR activity in interlobular 
ducts by fluid secretion measurement. Therefore, the CFTR ion channel expression in mouse 
pancreatic interlobular ducts is low in contrast with intercalated ducts. Based on our results, 
the measured increase in ductal HCO3
-
 secretion at 6 h after AP initiation mainly relates to 
activation of transporters other than CFTR, e.g. SLC26A3, SLC26A6, ANO1, NBC, NHE or 
H
+
-ATPase. Our previous publications presented that etiological factors like ethanol or its 
metabolites and bile acids concentration dependently stimulate or inhibit the function of ducts 
(Judák et al., 2014; Maléth et al., 2011 and 2015; Venglovecz et al., 2008). These 
investigations used ducts derived from guinea-pig, which have prominent CFTR ion channel 
expression in interlobular ducts and could be activated by CFTR agonists (e.g. cAMP; 
Ishiguro et al., 2009).  
Previous publications (Judák et al., 2014; Maléth et al., 2011 and 2015; Venglovecz et 
al., 2008) and the present work suggest that etiological factors of AP or pancreatitis itself 
initiates CFTR mislocalization or degradation, and inhibition of fluid secretion. These factors 
possibly contribute to increased pancreatic inflammation. We supposed that pharmacological 
correction of ductal function should reduce pancreatic damage and acinar necrosis/apoptosis 
of the disease. For this reason, the combination of CFTR corrector, VX-661 and potentiator, 
VX-770 was used. Pre-treatment of mice with VX-661+VX-770 significantly decreased the 
pancreatic tissue damage during AP; however, other inflammatory parameters were similar to 
the AP group. Interestingly, the expression and localization of CFTR protein was not changed 
by the VX-661 + VX-770 treatment.  Since the expression of CFTR was unchanged after 
VX-661+VX-770 treatments, we suppose that the residual and functional CFTR proteins in 
pancreatic ducts were activated, and this could lead to the observed decrease in acinar 
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damage. As localization of CFTR protein was unchanged, we think that the beneficial effect 
in AP was mainly related to the use of CFTR potentiator (VX-770).  
We could demonstrate that CFTR correction and potentiation by VX molecules increases 
fluid secretion in pancreatic ducts isolated from AP mice. We hypothesize that ductal 
secretion defends the pancreas by washing out toxic agents like activated digestive enzymes. 
If this defence mechanism is insufficient, the harmful agents cannot be eliminated from the 
pancreas, and this can result in tissue damage. Previously, Niderau et al. (1985) and Renner et 
al. (1983) showed that fluid secretion stimulated by secretin has protective effects in AP. 
Furthermore, galanin inhibits basal bicarbonate secretion which exacerbates the inflammation 
of pancreas (Brodish et al., 1994; Hegyi et al., 2011). Overall, it seems that fluid secretion is 
an important protecting mechanism which can be enhanced in AP by VX-661 + VX-770 
treatment. 
Zeng et al. (2017) in autoimmune pancreatitis also successfully applied a CFTR corrector 
(C18) and VX-770, which reduced the extent of inflammation. They observed that increasing 
CFTR expression (C18) and activity (VX-770), enhanced ductal fluid secretion and clearance 
of the inflammation to allow repair of cell damage. However, they found that the correction 
by C18 caused the majority of the effects, and the effect of VX-770 was negligible in that 
model. In our study, we applied only one AP model, which is a limitation of this work. The 
secretagogue model utilized in the present investigation damages mainly the pancreatic acinar 
cells. It would be interesting to test the efficacy of CFTR correction or potentiation in a 
model where the damage of ducts is likely to initiate the disease. The intraductal taurocholic 
acid-induced AP model could be used for this reason, which is a well-accepted model of 
biliary pancreatitis.  
Taken together, this study demonstrated CFTR mislocalization and the change of 
expression during the course of cerulein-induced AP in mice. We also showed that treatment 
with CFTR correctors and potentiators may offer new option to treat this disease. 
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Legends 
 
Figure 1. Schematic representation of experimental protocols 
Experimental protocol for investigating A, the time course of cerulein-induced acute 
pancreatitis (AP) severity in FVB/n mice; B, the effect of CFTR corrector (VX-661) and 
potentiator (VX-770) on AP. Arrows and syringe pictograms above the timeline indicate 
cerulein and VX-661/VX-770 treatments, respectively. Control animals were injected with 
physiological saline (PS) instead of cerulein and DMSO instead of VX compounds. The 
scalper and red numbers indicate the times of sacrifice in h. 
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Figure 2. Disease severity course in cerulein-induced acute pancreatitis 
A, Representative H&E histopathological images of pancreatic tissues from mice. The groups 
were established based on time of sacrifice after AP induction (first cerulein injection): 0, 6, 
12, 24, 48, 72 hours. Scale bar represents 100 µm. Bar charts show the extent of pancreatic B, 
cellular damage; C, vacuolization; D, leukocyte infiltration; E, myeloperoxidase (MPO) 
activity; F, water content; and G, serum amylase activity. Values represent means with 
standard deviation, n=6-8. One-way ANOVA was performed followed by Tukey HSD post-
hoc test. Statistically significant differences (p<0.05) were detected and marked with: (a) vs. 
0h; (b) vs. 6h; (c) vs. 12h; (d) vs. 24h. 
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Figure 3. Relative gene expression of Cftr, Ck19, Slc26a3, Slc26a6 and immunostainings 
of CFTR and CK19 proteins during the course of acute pancreatitis 
Bar charts show the relative gene expression of A, Cftr; B, Ck19; C, Slc26a3; and D, Slc26a6. 
Representative immunofluorescent or fluorescent images (CFTR, CK19, and cellular nuclei 
stainings) of pancreatic tissues from control and Cer-treated animals. Scale bar is 100 µm. 
Bar charts show the staining area of F, CFTR and G, CK19 proteins. Values represent means 
with standard deviation, n=3-7. One-way ANOVA was performed followed by Tukey HSD 
post-hoc test. Statistically significant differences (p<0.05) were detected and marked with: (a) 
vs. 0h; (b) vs. 6h; (c) vs. 12h; (d) vs. 24h; (e) vs. 48h. 
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Figure 4. The pancreatic ductal morphology during acute pancreatitis 
Fluorescent immunostaining of cystic fibrosis transmembrane conductance regulator (CFTR, 
green), cytokeratin-19 (CK19, red) proteins and cellular nuclei (blue) in pancreatic tissue of 
mice with AP observed at 0, 6, 12, 24, 48, 72 h after AP induction. Scale bar = 20 µm.  
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Figure 5. Ductal HCO3
− 
secretion during the course of acute pancreatitis 
Intra-/interlobular pancreatic ducts were isolated from control (0 h) and AP mice 6-72 h after the first 
cerulein injection. The measurements of intracellular pH changes (ΔpHi) are plotted for 
regeneration from A, alkalosis and B, acidosis. Values represent means with standard 
deviation, n=4-9 ducts. One-way ANOVA was performed followed by Tukey HSD post-hoc 
test. Statistically significant differences (p<0.05) were detected and marked with: (a) vs. 0h; 
(b) vs. 6h.  
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Figure 6. The effect of CFTR corrector VX-661 and CFTR potentiator VX-770 on the 
severity of acute pancreatitis  
A, Representative histopathological images of pancreatic tissues of the treatment groups at 24 
or 48 h termination. Bar charts show the extent of pancreatic B, cellular damage; C, 
vacuolization; D, leukocyte infiltration; E, myeloperoxidase (MPO) activity; F, water 
content; and G, serum amylase activity measurements. Light and dark grey bars show 24 and 
48 h measurements, respectively. Values represent means with standard deviation, n=5-6. 
Two-way ANOVA was performed followed by Tukey HSD post-hoc test. 
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Figure 7. The effect of VX-661 and VX-770 on ductal morphology during acute 
pancreatitis 
Immunofluorescent staining of CFTR (green) and CK19 (red) proteins and cellular nuclei 
(blue) in pancreatic tissues from mice at 24 or 48 h after AP induction. Treatment groups: 
control; Cer-induced AP; Cer-induced AP+VX-661+VX-770. Scale bar = 20 µm.  
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Figure 8. The effect of VX-661 and VX-770 on the protein expression of CFTR and 
CK19 during acute pancreatitis 
A, Representative immunofluorescent images (CFTR, CK19, and cellular nuclei stainings) of 
pancreatic tissues. Treatment groups: control; Cer-induced AP; Cer-induced AP+VX-
661+VX-770. Bar charts show the staining area of B, CFTR and C, CK19 proteins. Scale bar 
is 100 µm. Light and dark grey bars show 24 and 48 h measurements, respectively. Values 
represent means with standard deviation, n=3-5. Two-way ANOVA was performed followed 
by Tukey HSD post-hoc test. 
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Figure 9. The effect of VX-661 and VX-770 on the fluid secretion of isolated pancreatic 
ducts  
Intra-/interlobular pancreatic ducts were isolated from control and AP mice 6 h after the first cerulein 
injection. Thereafter, ducts were cultured for 6-14 h (which allowed sealing of their open ends) at 37 
°C in a humidified atmosphere containing 5% CO2. 3 µM VX-661 and 1 µM VX-770 or their 
vehicle (DMSO) were administered in the culture media of some AP ducts. Since DMSO had no 
effect on the swelling of ducts isolated from AP mice, the corresponding groups treated with or 
without DMSO (media) were combined. A, the line diagram shows changes in relative luminal 
volume of pancreatic ducts derived from control and AP mice with or without VX treatment 
in response to administration of standard HEPES and HCO3
-
/CO2 containing solutions. Fluid 
secretion was stimulated with the cAMP agonist forskolin. B, Bar charts show the relative 
luminal volume measured before the end of ‘standard HEPES buffer + forskolin’ (light bars) 
and ‘standard HCO3
-
/CO2 buffer + forskolin’ (dark bars) perfusion. Values represent means 
with standard deviation, n=7-17. Two-way ANOVA was performed followed by Tukey HSD 
post-hoc test. 
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